Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research
- PMID: 9731714
- DOI: 10.1097/00008571-199808000-00001
Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research
Abstract
Twin studies are useful devices to determine the heritability of persistent but variable characteristics that tend to differ among individuals. Drug responses are not persistent affairs; they are temporary characteristics. One therefore may ask whether twin studies are necessary to assess the genetic element in pharmacological responsiveness. To measure the genetic component contributing to their variability, it seems logical to investigate the response variation by repeated drug administration to given individuals, and to compare the variability of the responses within and between individuals. We attempt here to describe a theoretical background of this venture, and to show some results of the exercise. Potential sources of error or uncertainty are discussed.
Similar articles
-
Repeat administration of drugs as a means to assess the genetic component in pharmacological variability.Pharmacology. 1999 Jun;58(6):281-4. doi: 10.1159/000028292. Pharmacology. 1999. PMID: 10325572 Review. No abstract available.
-
Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.Eur J Pharm Sci. 2019 Mar 15;130:65-77. doi: 10.1016/j.ejps.2019.01.024. Epub 2019 Jan 23. Eur J Pharm Sci. 2019. PMID: 30684656 Review.
-
Classical twin design in modern pharmacogenomics studies.Pharmacogenomics. 2010 Feb;11(2):215-26. doi: 10.2217/pgs.09.171. Pharmacogenomics. 2010. PMID: 20136360 Review.
-
Estimating the extent of parameter bias in the classical twin design: a comparison of parameter estimates from extended twin-family and classical twin designs.Twin Res Hum Genet. 2005 Jun;8(3):214-23. doi: 10.1375/1832427054253121. Twin Res Hum Genet. 2005. PMID: 15989749
-
Toxicological implications of polymorphic drug metabolism.Ciba Found Symp. 1980;76:219-44. doi: 10.1002/9780470720592.ch12. Ciba Found Symp. 1980. PMID: 6906263
Cited by
-
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.Genomics Proteomics Bioinformatics. 2016 Oct;14(5):298-313. doi: 10.1016/j.gpb.2016.03.008. Epub 2016 Oct 8. Genomics Proteomics Bioinformatics. 2016. PMID: 27729266 Free PMC article. Review.
-
Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China.Pharmgenomics Pers Med. 2021 Dec 17;14:1647-1660. doi: 10.2147/PGPM.S327313. eCollection 2021. Pharmgenomics Pers Med. 2021. PMID: 34949935 Free PMC article.
-
Biomarkers for stroke.J Stroke. 2013 Jan;15(1):27-37. doi: 10.5853/jos.2013.15.1.27. Epub 2013 Jan 31. J Stroke. 2013. PMID: 24324937 Free PMC article. Review.
-
Impact of germline and somatic missense variations on drug binding sites.Pharmacogenomics J. 2017 Mar;17(2):128-136. doi: 10.1038/tpj.2015.97. Epub 2016 Jan 26. Pharmacogenomics J. 2017. PMID: 26810135 Free PMC article.
-
Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.Int J Mol Sci. 2017 Jan 31;18(2):308. doi: 10.3390/ijms18020308. Int J Mol Sci. 2017. PMID: 28146134 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical